Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference2%
- Check53 days agoChange DetectedThe website has added new features or content, while several detailed options related to participant groups, interventions, and data download formats have been removed.SummaryDifference4%
- Check60 days agoChange DetectedSeveral key health-related links have been removed, including resources from MedlinePlus, DailyMed, and various government health sites.SummaryDifference0.4%
- Check67 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to genetics, clinical trials, and treatment options, while removing the previous version 2.12.1.SummaryDifference4%
Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.